MOHW reclassified drugs by 61.5% prescriptions and 38.5% non-prescriptions.

The MOHW has completed a reclassification work and officially announced for the total 27,962 products as 61.5% (17,187 items) of prescription and 38.5% (10,775 items) of non-prescription drugs. This issue has been one of major disputes raised by the medical community so far.

Director Song Jae-sung, the MOHW Bureau of Health Policy explained in the briefing at 10:30 a.m. on May 30 over the fi...